FDA approves first medicine for post-partum depression

Published March 21, 2019
The drug named Zulresso needs to be administered intravenously in a hospital over the course of 60 hours. — AFP/File
The drug named Zulresso needs to be administered intravenously in a hospital over the course of 60 hours. — AFP/File

WASHINGTON: US authorities on Tuesday approved the first medication designed specifically to treat post-partum depression, an illness that affects about one in nine new American mothers.

The drug is called brexanolone from a company called Sage Therapeutics and one advantage is that it works quickly, in two days, whereas traditional anti-depressants can take weeks or months to kick in.

The drug’s trade name is Zulresso. It has been approved by the Food and Drug Administration (FDA).

But it needs to be administered intravenously in a hospital over the course of 60 hours because of the risk of fainting that was observed in some women during clinical tests.

“Post-partum depression is a serious condition that, when severe, can be life-threatening. Women may experience thoughts about harming themselves or harming their child,” said Tiffany Farchione, acting director of the division of psychiatry products in the FDA’s Center for Drug Evaluation and Research.

“This approval marks the first time a drug has been specifically approved to treat post-partum depression, providing an important new treatment option,” she added.

The most common secondary effects include drowsiness and dryness of the mouth.

Sage Therapeutics said the medication will be available in late June in the US.

US media say the treatment will cost $34,000 a year for people without health insurance. Insurers get it at a discounted rate. The full rate is without the cost of the hospital stay for administering it.

The Centers for Disease Control and Prevention say 11.5 per cent of new mothers suffered from post-partum depression in 2012.

Published in Dawn, March 21st, 2019

Opinion

Editorial

Energy inflation
23 May, 2024

Energy inflation

ON Tuesday, the Oil & Gas Regulatory Authority slashed the average prescribed gas prices of SNGPL by 10pc and...
Culture of violence
23 May, 2024

Culture of violence

WHILE political differences are part of the democratic process, there can be no justification for such disagreements...
Flooding threats
23 May, 2024

Flooding threats

WITH temperatures in GB and KP forecasted to be four to six degrees higher than normal this week, the threat of...
Bulldozed bill
Updated 22 May, 2024

Bulldozed bill

Where once the party was championing the people and their voices, it is now devising new means to silence them.
Out of the abyss
22 May, 2024

Out of the abyss

ENFORCED disappearances remain a persistent blight on fundamental human rights in the country. Recent exchanges...
Holding Israel accountable
22 May, 2024

Holding Israel accountable

ALTHOUGH the International Criminal Court’s prosecutor wants arrest warrants to be issued for Israel’s prime...